DTIL

#3503
Precision BioSciences, Inc. Common Stock
4.20
+7.42%
Secteur:
Base:
Devise de Profit:
Range quotidien
4.20
4.20
Range Annuel
3.53
8.82
Changement quotidien
+7.42%
Changement Mensuel
+2.94%
Evolution sur 6 mois
-16.67%
Changement Annuel
-22.22%
Clôture Précédente
3.91
Open
4.20
Bid
Ask
Low
4.20
High
4.20
Volume
5
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

Precision BioSciences Inc

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

Nouvelles